Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39,488Revenue $M10,235Net Margin (%)14.5Z-Score3.5
Enterprise Value $M43,309EPS $3.6Operating Margin %18.6F-Score6
P/E(ttm))26.7Cash Flow Per Share $5.3Pre-tax Margin (%)17.8Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %6.6Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %6.1Current Ratio1.8Lower Leverage y-yY
Price/Cash Flow11.0y-y EBITDA Growth Rate %-4.8ROA % (ttm)7.6Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)2ROE % (ttm)15.9Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M452ROI % (ttm)10.6Gross Margin Increase y-yN

Gurus Latest Trades with COV

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVJohn Paulson 2014-06-30 Buy 2.7%$69.03 - $91.24
($74.56)
$ 87.4117%New holding, 7000000 sh.7,000,000
COVGeorge Soros 2014-06-30 Buy 0.15%$69.03 - $91.24
($74.56)
$ 87.4117%New holding, 227000 sh.227,000
COVJoel Greenblatt 2014-06-30 Sold Out $69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVBill Nygren 2014-06-30 Reduce-1.51%$69.03 - $91.24
($74.56)
$ 87.4117%Reduce -94.09%160,000
COVRobert Olstein 2014-06-30 Sold Out -0.95%$69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVDonald Yacktman 2014-06-30 Sold Out -0.55%$69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVRay Dalio 2014-06-30 Sold Out -0.03%$69.03 - $91.24
($74.56)
$ 87.4117%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 87.4126%New holding, 3746 sh.3,746
COVRay Dalio 2014-03-31 Reduce-0.02%$66.35 - $72.5
($69.62)
$ 87.4126%Reduce -41.8%47,058
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 87.4134%Add 24.79%4,994,700
COVRay Dalio 2013-12-31 Buy 0.04%$59.82 - $68.42
($65.08)
$ 87.4134%New holding, 80858 sh.80,858
COVPrivate Capital 2013-12-31 Reduce-0.8%$59.82 - $68.42
($65.08)
$ 87.4134%Reduce -36.57%244,555
COVHOTCHKIS & WILEY 2013-12-31 Reduce-0.16%$59.82 - $68.42
($65.08)
$ 87.4134%Reduce -46.79%657,000
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 87.4134%Reduce -52.66%44,520
COVJoel Greenblatt 2013-12-31 Sold Out -0.03%$59.82 - $68.42
($65.08)
$ 87.4134%Sold Out0
COVRobert Olstein 2013-09-30 Add0.24%$57.12 - $63.8
($61.08)
$ 87.4143%Add 40%91,000
COVJoel Greenblatt 2013-09-30 Reduce-0.08%$57.12 - $63.8
($61.08)
$ 87.4143%Reduce -64.08%16,584
COVRobert Olstein 2013-06-30 Buy 0.65%$50.69 - $56.84
($54.09)
$ 87.4162%New holding, 65000 sh.65,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
COV George Soros 2014-06-30227,0000.050.15New Buy
COV John Paulson 2014-06-307,000,0001.552.7New Buy
COV Mario Gabelli 2014-06-30637,5300.140.3+17.29%
COV Ronald Muhlenkamp 2014-06-30182,1800.042.9+0.4%
COV HOTCHKIS & WILEY 2014-06-30788,7000.170.25+0.04%
COV Jean-Marie Eveillard 2014-06-301,50000
COV Vanguard Health Care Fund 2014-06-304,994,7001.111.2
COV Private Capital 2014-06-30238,7150.052.5-2.09%
COV John Keeley 2014-06-3040,8400.010.07-6.69%
COV Dodge & Cox 2014-06-3092,0170.020.01-9.36%
COV Bill Nygren 2014-06-30160,0000.040.1-94.09%
COV Donald Yacktman 2014-06-30000Sold Out
COV Joel Greenblatt 2014-06-30000Sold Out
COV Ray Dalio 2014-06-30000Sold Out
COV Yacktman Fund 2014-06-30000Sold Out
COV Yacktman Focused Fund 2014-06-30000Sold Out
COV Robert Olstein 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lannum Coleman N IIIVice President 2014-08-27Buy3,338$87.230.8view
Lannum Coleman N IIIVice President 2014-08-26Buy1,736$87.460.54view
Lannum Coleman N IIIVice President 2014-08-19Buy1,720$87.820.13view
Lannum Coleman N IIIVice President 2014-08-18Buy4,100$87.580.4view
BROWN RICHARD G JRVice President and Controller 2014-08-18Buy2,000$87.690.27view
ALMEIDA JOSE EPresident and Chief Executive 2014-06-16Sell51,166$92.05-4.48view
King Brian DouglasVice President 2014-04-29Sell15,569$70.1125.42view
Dockendorff Charles JEVP & CFO 2014-03-28Sell90,730$72.521.28view
ALMEIDA JOSE EPresident and Chief Executive 2014-02-28Sell50,000$7222.13view
Lannum Coleman N IIIVice President 2014-02-18Sell3,200$71.423.15view

Press Releases about COV :

Quarterly/Annual Reports about COV:

News about COV:

Articles On GuruFocus.com
Medical Technology Company Offers Investment Opportunity Sep 25 2014 
Gabelli Value 25 Fund Second Quarter Commentary Sep 15 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Abbott: A Brighter Future Aug 28 2014 
A Strong Candidate for Investor´s Portfolios Aug 12 2014 
The Gabelli Equity Income Fund Second Quarter 2014 Shareholder Commentary Jul 25 2014 
Steven Romick's Top Five Stocks Jul 11 2014 
American Water Works - Nice Steady Upward Jun 21 2014 
Major British Companies Lead Top Guru-Held UK and Ireland Stocks Jun 10 2014 
4 Top Stocks in the Medical Device Sector Apr 11 2014 

More From Other Websites
93% of U.S., 92% of New Yorkers Unaware that Stroke is Second Leading Cause of Death Globally Oct 22 2014
93% of U.S., 92% of New Yorkers Unaware that Stroke is Second Leading Cause of Death Globally Oct 22 2014
Monday’s Notable Options Activity Oct 21 2014
Covidien faces huge bearish trade Oct 21 2014
[$$] Covidien Wins Patent Injunction Against J&J Oct 17 2014
U.S. District Court Grants Covidien Preliminary Injunction against Ethicon’s Harmonic ACE®+7 Oct 17 2014
U.S. District Court Grants Covidien Preliminary Injunction against Ethicon’s Harmonic ACE®+7 Oct 17 2014
[video] AbbVie directors recommend against Shire deal Oct 16 2014
Covidien (COV) in Focus: Stock Falls 7% Oct 16 2014
Today's Market Thorns, Roses, and All Time Highs... Oct 15 2014
Shire Urges AbbVie to Pursue Merger Despite New Inversion Rules Oct 15 2014
Medtronic Reveals Restructuring Plan post Covidien Buy Oct 13 2014
Medtronic seeks EU approval for $43 bln Covidien deal Oct 13 2014
Medtronic seeks EU approval for $43 bln Covidien deal Oct 13 2014
Covidien Gets FDA Clearance for Patient Monitoring System Oct 10 2014
Announcement Under Irish Takeover Rules Relevant Securities In Issue – October 10, 2014 Oct 10 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – October 10, 2014 Oct 10 2014
Announcement under Irish Takeover Rules Relevant Securities in Issue – October 10, 2014 Oct 10 2014
[$$] Medtronic's Omar Ishrak to Remain CEO After Covidien Acquisition Oct 10 2014
Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for Nellcor™ Portable SpO2... Oct 09 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK